Dr. Muhammad Irfan, MD

Dr. Irfan practices at Family Diagnostic Clinic in Tomball, Texas.

Dr. Irfan's NPI, 1972570489, was assigned on March 2, 2006. Dr. Irfan graduated from Dow University of Health Sciences in 1991. Dr. Irfan holds Texas license KO836.

Dr. Irfan's primary practice is Family Diagnostic Clinic, at 27721 Tomball Pkwy, Tomball, TX 77375 in Harris County. The practice phone is (281) 351-6800.

Dr. Irfan's primary practice is Family Diagnostic Clinic in Tomball, Texas. Dr. Irfan is also affiliated with HCA Houston Healthcare Tomball. The medical group on file is Family Diagnostic Clinic. Dmand AI also links Dr. Irfan to 2 more hospitals, 2 home health agencies, 1 group practice or clinic, 1 hospice and 1 skilled nursing facility, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Irfan practices, 8 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Irfan's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Irfan is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Irfan's licenses on file in 3 states: Texas, Indiana and Michigan.

Dmand AI lists acid reflux, acute diabetes, acute kidney failure, acute respiratory failure, acute skin infection, anemia, aneurysm and anxiety among the conditions Dr. Irfan treats.

CMS data shows 3,956 Medicare services from Dr. Irfan across 26 procedure codes in 2024, for 489 Medicare patients. Medicare paid $242,882 for them.

CMS counts 489 Medicare patients who saw Dr. Irfan in 2024. The largest group is 65 to 74, with 186 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.45, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Irfan's median patient age at 68, with 54% women.

In 2024, Dr. Irfan wrote 12,878 Medicare Part D claims for 730 patients. 84% of them were for generic drugs. CMS names the drug for 12,022 of them, across 198 drugs with 11 or more claims each, at $1,274,231 in total drug cost. In 2023, CMS named 13,473 claims across 206 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Irfan for performance year 2024, reported as part of a group. Dr. Irfan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Irfan as offering telehealth.

Dmand AI links 9 papers to Dr. Irfan, published from 2014 to 2025. 2020 was the busiest year, with 2. Dr. Irfan has published most often in Cureus.

Dmand AI links Dr. Irfan to 11 clinical trials, 3 of them phase 3 studies. Conditions studied include Colitis, Ulcerative, Colitis and Migraine without Aura. Eli Lilly and Company sponsors the most, 3. Open Payments lists research payments to Dr. Irfan that name 2 trials.

CMS Open Payments shows 301 general payments to Dr. Irfan from 46 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 61% of the total. Novo Nordisk Inc paid the most, $3,666. It also lists 17 research payments totaling $50,665 from 2022 to 2025, naming 2 clinical trials.

Dmand AI lists 1 award for Dr. Irfan, most recently CMS Stage 1 EHR in 2013.

Dr. Irfan graduated from Dow University of Health Sciences in 1991.

Dr. Irfan is in network with 25 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 15. Check the plan with the practice before a visit.